Morphogenic Peptides in Regeneration of Load Bearing Tissues
- PMID: 26545746
- DOI: 10.1007/978-3-319-22345-2_6
Morphogenic Peptides in Regeneration of Load Bearing Tissues
Abstract
Morphogenic proteins due to their short half-life require high doses of growth factors in regeneration of load bearing tissues which leads to undesirable side effects. These side effects include bone overgrowth, tumor formation and immune reaction. An alternative approach to reduce undesirable side effects of proteins in regenerative medicine is to use morphogenic peptides derived from the active domains of morphogenic proteins or soluble and insoluble components of the extracellular matrix of mineralized load bearing tissues to induce differentiation of progenitor cells, mineralization, maturation and bone formation. In that regard, many peptides with osteogenic activity have been discovered. These include peptides derived from bone morphogenic proteins (BMPs), those based on interaction with integrin and heparin-binding receptors, collagen derived peptides, peptides derived from other soluble ECM proteins such as bone sialoprotein and enamel matrix proteins, and those peptides derived from vasculoinductive and neuro-inductive proteins. Although these peptides show significant osteogenic activity in vitro and increase mineralization and bone formation in animal models, they are not widely used in clinical orthopedic applications as an alternative to morphogenic proteins. This is partly due to the limited availability of data on structure and function of morphogenic peptides in physiological medium, particularly in tissue engineered scaffolds. Due to their amphiphilic nature, peptides spontaneously self-assemble and aggregate into micellar structures in physiological medium. Aggregation alters the sequence of amino acids in morphogenic peptides that interact with cell surface receptors thus affecting osteogenic activity of the peptide. Aggregation and micelle formation can dramatically reduce the active concentration of morphogenic peptides with many-fold increase in peptide concentration in physiological medium. Other factors that affect bioactivity are the non-specific interaction of morphogenic peptides with lipid bilayer of the cell membrane, interaction of the peptide with cell surface receptors that do not specifically induce osteogenesis leading to less-than-optimal osteogenic activity of the peptide, and less-than-optimal interaction of the peptide with osteogenic receptors on the cell surface. Covalent attachment or physical interaction with the tissue engineered matrix can also alter the bioactivity of morphogenic peptides and lead to a lower extent of osteogenesis and bone formation. This chapter reviews advances in discovery of morphogenic peptide, their structural characterization, and challenges in using morphogenic peptides in clinical applications as growth factors in tissue engineered devices for regeneration of load bearing tissues.
Keywords: BMP; Bone regeneration; Growth factor delivery; Hydrogel; Peptide conjugation; Stem cells; Tissue engineering.
Similar articles
-
Osteogenic peptides in bone regeneration.Curr Pharm Des. 2013;19(19):3391-402. doi: 10.2174/1381612811319190006. Curr Pharm Des. 2013. PMID: 23432672 Review.
-
Osteogenic effects of covalently tethered rhBMP-2 and rhBMP-9 in an MMP-sensitive PEG hydrogel nanocomposite.Acta Biomater. 2023 Oct 15;170:53-67. doi: 10.1016/j.actbio.2023.08.045. Epub 2023 Aug 26. Acta Biomater. 2023. PMID: 37634836
-
Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.Vitam Horm. 2015;99:293-322. doi: 10.1016/bs.vh.2015.06.002. Epub 2015 Jul 15. Vitam Horm. 2015. PMID: 26279381 Review.
-
Bioactive cell-derived matrices combined with polymer mesh scaffold for osteogenesis and bone healing.Biomaterials. 2015 May;50:75-86. doi: 10.1016/j.biomaterials.2015.01.054. Epub 2015 Feb 16. Biomaterials. 2015. PMID: 25736498
-
BMP-2 peptide-functionalized nanopatterned substrates for enhanced osteogenic differentiation of human mesenchymal stem cells.Biomaterials. 2013 Oct;34(30):7236-46. doi: 10.1016/j.biomaterials.2013.06.019. Epub 2013 Jul 3. Biomaterials. 2013. PMID: 23830472
Cited by
-
Advances in Skin Tissue Engineering and Regenerative Medicine.J Burn Care Res. 2023 Jan 2;44(Suppl_1):S33-S41. doi: 10.1093/jbcr/irac126. J Burn Care Res. 2023. PMID: 36567474 Free PMC article.
-
Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives.Biomaterials. 2018 Oct;180:143-162. doi: 10.1016/j.biomaterials.2018.07.017. Epub 2018 Jul 11. Biomaterials. 2018. PMID: 30036727 Free PMC article. Review.
-
Dose-dependence of PTH-related peptide-1 on the osteogenic induction of MC3T3-E1 cells in vitro.Medicine (Baltimore). 2017 Apr;96(17):e6637. doi: 10.1097/MD.0000000000006637. Medicine (Baltimore). 2017. PMID: 28445262 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources